The Cancer Letter

Inside information on cancer research and drug development

Vol.
33
No.
4
April 30, 2010Apr 30, 2010
Free
DOWNLOAD THE PDF

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

Controlling Diabetes May Cut Liver Cancer Risk, Study Finds

Colorectal Cancer Screening Practices Need Improvement, CDC Practice Study Finds

Healthcare Utilization Figures More Than Biology In Disparity

Phase III Lung and Pancreatic Cancer Trials Are Stopped

NCI Cooperative Group Clinical Trials Approved

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account